Advances in copper complexes as anticancer agents.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Chemical Reviews

• Publication date

  2014-01-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/cr400135xPMID 24102434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular and cellular pharmacology Anti-cancer activity and mutagenic potential of novel copper ( II ) quinolinone Schiff base complexes in hepatocarcinoma cells

  2016cited by this paper
• Targeting and delivery of platinum-based anticancer drugs.

  2013cited by this paper
• Targeting cellular metabolism to improve cancer therapeutics

  2013cited by this paper
• Synthesis, DNA binding and antiproliferative activity of ternary copper complexes of moxifloxacin and gatifloxacin against lung cancer cells

  2012cited by this paper
• Copper complexes as therapeutic agents.

  2012cited by this paper
• Synthesis, structure, electrochemical properties, cytotoxic effects and antioxidant activity of 5-amino-8-methyl-4H-benzopyran-4-one and its copper(II) complexes

  2012cited by this paper
• Synthesis and structure of new tetracopper(II) complexes bridged by 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate: DNA-binding and anticancer activity.

  2012cited by this paper
• Copper(I) and nickel(II) complexes with 1:1 vs. 1:2 coordination of ferrocenyl hydrazone ligands: do the geometry and composition of complexes affect DNA binding/cleavage, protein binding, antioxidant and cytotoxic activities?

  2012cited by this paper
• Bimetallic complexes constructed from asymmetrical N,N'-bis(substituted)-oxamide: cytotoxicities, and reactivities towards DNA and protein.

  2012cited by this paper
• CuII ions and the stilbene-chroman hybrid with a catechol moiety synergistically induced DNA damage, and cell cycle arrest and apoptosis of HepG2 cells: an interesting acid/base-promoted prooxidant reaction.

  2012cited by this paper
• Study on ligation of copper complexes of the quinolone antibacterial drugs and octamolybdates POMs

  2012cited by this paper
• Synthesis, structural characterization, antimicrobial and cytotoxic effects of aziridine, 2-aminoethylaziridine and azirine complexes of copper(II) and palladium(II).

  2012cited by this paper
• Potent oxidative DNA cleavage by the di-copper cytotoxin: [Cu2(μ-terephthalate)(1,10-phen)4]2+.

  2012cited by this paper
• DNA binding, DNA cleavage and cytotoxicity studies of a new water soluble copper(II) complex: the effect of ligand shape on the mode of binding.

  2012cited by this paper
• Synthesis, structure, DNA-binding properties and cytotoxic activities of a new one-dimensional polymeric copper(II) complex with N-benzoate-N′-[3-(2-hydroxyl-ethylammino)propyl]oxamide as ligand

  2012cited by this paper
• Synthesis and structures of binuclear copper(II) complexes bridged by N-(5-chloro-2-hydroxyphenyl)-N′-[3-(dimethylamino)propyl]oxalamide ligand: DNA-binding properties and cytotoxic activities

  2012cited by this paper
• Molecular drug design, synthesis and structure elucidation of a new specific target peptide based metallo drug for cancer chemotherapy as topoisomerase I inhibitor.

  2012cited by this paper
• Anti-cancer activity and mutagenic potential of novel copper(II) quinolinone Schiff base complexes in hepatocarcinoma cells.

  2012cited by this paper
• Metal complexes as inhibitors of the 26S proteasome in tumor cells.

  2012cited by this paper
• 1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity

  2012cited by this paper
• Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation

  2012cited by this paper
• ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.

  2012cited by this paper
• ATRA-hydrazonate derivatives and their copper complexes against hormone-dependent (MCF-7), hormone-independent (MDA-MB-231and BT-20) breast cancer and androgen-independent (PC3) prostate cancer cell lines

  2012cited by this paper
• Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand

  2012cited by this paper
• Dinuclear copper(II) complexes with valsartan. Synthesis, characterization and cytotoxicity.

  2012cited by this paper
• Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: the role of co-ligand planarity on DNA binding and cleavage and anticancer activity.

  2012cited by this paper
• Synthesis, characterization, DNA binding and cytotoxicity studies of moxifloxacinato complexes

  2012cited by this paper
• Molecular basis of structure-activity relationships between salphen metal complexes and human telomeric DNA quadruplexes.

  2012cited by this paper
• Chemical bonding descriptors based on electron density inhomogeneity measure: a comparison with ELI-D

  2012cited by this paper
• Copper(II) complexes of terpyridine derivatives: a footstep towards development of antiproliferative agent for breast cancer.

  2012cited by this paper
• Radical-induced DNA damage by cytotoxic square-planar copper(II) complexes incorporating o-phthalate and 1,10-phenanthroline or 2,2'-dipyridyl.

  2012cited by this paper
• Synthesis and Structure of 1D Copper(II) Polymers with Dissymmetrical N,N′-Bis(substituted)oxamide Ligands: Cytotoxicity and DNA-Binding Property

  2012cited by this paper
• Copper coordination to the putative cell binding site of angiogenin: a DFT investigation

  2012cited by this paper
• Copper(II) complexes with norfloxacin and neutral terpyridines: Cytotoxic, antibacterial, superoxide dismutase and DNA-interaction approach

  2012cited by this paper
• Nuclease activity via self-activation and anticancer activity of a mononuclear copper(II) complex: novel role of the tertiary butyl group in the ligand frame.

  2012cited by this paper
• A tri-copper(II) complex displaying DNA-cleaving properties and antiproliferative activity against cancer cells.

  2012cited by this paper
• Metal complexes of a novel bis-β-diketone-type ligand and its copper(II) complexes of two-photon biological imaging

  2012cited by this paper
• Synthesis, spectral investigation and biological interphase of drug‐based cytotoxic square pyramidal coordination compounds

  2012cited by this paper
• DNA binding, nuclease activity and cytotoxicity studies of Cu(II) complexes of tridentate ligands.

  2012cited by this paper
• Synthesis, Structure, Cytotoxic Activities and DNA-Binding Properties of a 1D Copper(II) Complex Bridged both by Oxamidate and Terephthalato Groups

  2012cited by this paper
• Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV

  2012cited by this paper
• Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.

  2012cited by this paper
• Potential cytotoxic and amoebicide activity of first row transition metal compounds with 2,9-bis-(2',5'-diazahexanyl)-1,1-phenanthroline (L1).

  2012cited by this paper
• Synthesis, crystal structure, DNA-binding properties, cytotoxic and antioxidation activities of several ternary copper(II) complexes with a new reduced Schiff base ligand

  2012cited by this paper
• Structure–activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4′-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity

  2012cited by this paper
• The effect of dietary zinc - and polyphenols intake on DMBA-induced mammary tumorigenesis in rats

  2012cited by this paper
• Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines.

  2012cited by this paper
• Synthesis of novel heterobimetallic copper(I) hydrazone Schiff base complexes: a comparative study on the effect of heterocyclic hydrazides towards interaction with DNA/protein, free radical scavenging and cytotoxicity.

  2012cited by this paper
• Mononuclear copper(II) complex with terpyridine and an extended phenanthroline base, [Cu(tpy)(dppz)]2+: Synthesis, crystal structure, DNA binding and cytotoxicity activity

  2012cited by this paper
• Oxidative DNA cleavage, cytotoxicity and antimicrobial studies of l-ornithine copper (II) complexes

  2012cited by this paper
• Advances in metal-carbene complexes as potent anti-cancer agents.

  2012cited by this paper
• Coinage metal complexes against breast cancer.

  2012cited by this paper
• Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.

  2012cited by this paper
• Cytotoxic, DNA Interaction, SOD Mimic, and Antimicrobial Activities of Square Pyramidal Copper(II) Complexes†

  2012cited by this paper
• Interaction and photo-induced cleavage studies of a copper based chemotherapeutic drug with human serum albumin: spectroscopic and molecular docking study.

  2012cited by this paper
• Syntheses and structures of bicopper(II) complexes bridged by N-(5-chloro-2-hydroxyphenyl)-N′-[3-(dimethylamino)propyl]oxamide: Cytotoxic activities, and reactivities towards DNA and protein

  2012cited by this paper
• Synthesis, structural characterization and in vitro biological screening of some homoleptic copper(II) complexes with substituted guanidines.

  2012cited by this paper
• New heterobimetallic Cu(II)-Sn2(IV) complex as potential topoisomerase I inhibitor: in vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines.

  2012cited by this paper
• In vitro cytotoxicity, DNA cleavage and SOD-mimic activity of copper(II) mixed-ligand quinolinonato complexes.

  2012cited by this paper
• DNA binding and antiproliferative activity toward human carcinoma cells of copper(II) and zinc(II) complexes of a 2,5-diphenyl[1,3,4]oxadiazole derivative.

  2012cited by this paper
• Biological activity and structure dependent properties of cuprous iodide complexes with phenanthrolines and water soluble tris (aminomethyl) phosphanes.

  2011cited by this paper
• Synthesis and biological studies of 4', 7, 8-trihydroxy-isoflavone metal complexes.

  2011cited by this paper
• DNA interaction, superoxide scavenging and cytotoxicity studies on new copper(II) complexes derived from a tridentate ligand

  2011cited by this paper
• Ferrocene-conjugated L-tryptophan copper(II) complexes of phenanthroline bases showing DNA photocleavage activity and cytotoxicity.

  2011cited by this paper
• Characterization of physical interaction between Casiopeina III-ia and chitosan. Toward a Cas III-ia drug delivery system.

  2011cited by this paper
• A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling

  2011cited by this paper
• Evaluation of DNA binding, DNA cleavage, protein binding and in vitro cytotoxic activities of bivalent transition metal hydrazone complexes.

  2011cited by this paper
• Synthesis, characterization and anti-tumor activity of moxifloxacin-copper complexes against breast cancer cell lines.

  2011cited by this paper
• Synthesis, crystal structure, and in vitro antitumor activities of copper(II) complexes containing tetradentate pyridine-based ligands

  2011cited by this paper
• A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: cleavage and antitumor activity.

  2011cited by this paper
• Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.

  2011cited by this paper
• In vitro and in vivo antitumor activity of novel 3D-organotin supramolecular coordination polymers based on CuCN and pyridine bases

  2011cited by this paper
• Structural studies and anticancer activity of a novel (N6O4) macrocyclic ligand and its Cu(II) complexes.

  2011cited by this paper
• Cytotoxic copper(II) complex of tripyridoquinoxaline with DNA hydrolase activity

  2011cited by this paper
• Copper: an essential metal in biology.

  2011cited by this paper
• Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.

  2011cited by this paper
• π-Stacking between Casiopeinas® and DNA bases.

  2011cited by this paper
• Water-soluble bis(1,10-phenanthroline) Octanedioate Cu2+ and Mn2+ Complexes with Unprecedented Nano and Picomolar in Vitro Cytotoxicity: Promising Leads for Chemotherapeutic Drug Development

  2011cited by this paper
• Erratum To: N-Heterocyclic Carbenes in Transition Metal Catalysis and Organocatalysis

  2011cited by this paper
• Genotoxicity of the copper antineoplastic coordination complexes casiopeinas.

  2011cited by this paper
• Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.

  2011cited by this paper
• Preparation and pharmacochemical evaluation of mixed ligand copper(II) complexes with triethanolamine and thiophenyl-2 saturated carboxylic acids.

  2011cited by this paper
• Biological evaluation of a novel water soluble sulphur bridged binuclear copper(II) thiosemicarbazone complex.

  2011cited by this paper
• Synthesis, characterization, and study on HeLa cells activity of a dinuclear complex [Cu4(phen)4(H2O)2]·(pyri)·3H2O.

  2011cited by this paper
• Characterization of 2'-deoxyguanosine oxidation products observed in the Fenton-like system Cu(II)/H2O2/reductant in nucleoside and oligodeoxynucleotide contexts.

  2011cited by this paper
• Synthesis and structure of new bicopper(II) complexes bridged by N-(2- aminopropyl)-N'-(2-oxidophenyl)oxamide: the effects of terminal ligands on structures, anticancer activities and DNA-binding properties.

  2011cited by this paper
• Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes.

  2011cited by this paper
• Synthesis, electronic structure, DNA and protein binding, DNA cleavage, and anticancer activity of fluorophore-labeled copper(II) complexes.

  2011cited by this paper
• Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeína IIgly and cisplatin in murine melanoma B16 cells.

  2011cited by this paper
• Cytotoxic effect of a polymer–copper(II) complex containing 2,2′-bipyridyl ligand on human lung cancer cells

  2011cited by this paper
• Synthesis, DNA binding, photo-induced DNA cleavage, cytotoxicity and apoptosis studies of copper(II) complexes.

  2011cited by this paper
• In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.

  2011cited by this paper
• Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl-3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde.

  2011cited by this paper
• Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines

  2011cited by this paper
• Remarkable photocytotoxicity in hypoxic HeLa cells by a dipyridophenazine copper(II) Schiff base thiolate.

  2011cited by this paper
• Systematic coordination chemistry and cytotoxicity of copper(II) complexes with methyl substituted 4-nitropyridine N-oxides.

  2011cited by this paper
• Interaction with DNA and different effect on the nucleus of cancer cells for copper(II) complexes of N-benzyl di(pyridylmethyl)amine.

  2011cited by this paper
• Effect of N(4)-phenyl substitution in 2-oxo-1,2-dihydroquinoline-3-carbaldehyde semicarbazones on the structure, DNA/protein interaction, and antioxidative and cytotoxic activity of Cu(II) complexes.

  2011cited by this paper
• Synthesis, spectral characterization, solution equilibria, in vitro antibacterial and cytotoxic activities of Cu(II), Ni(II), Mn(II), Co(II) and Zn(II) complexes with Schiff base derived from 5-bromosalicylaldehyde and 2-aminomethylthiophene.

  2011cited by this paper
• Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity.

  2011cited by this paper

• Anticancer Activity of Schiff Base Metal Complexes Against MCF-7 Breast Cancer Cell Line

  2026cites this paper
• Isocyanide Incorporation Expands the Anticancer Potential of Diiron(I) Aminocarbyne Complexes.

  2026cites this paper
• Adsorption and sensing of vildagliptin on coinage metal nanoclusters: DFT, MD and spectroscopic insights

  2026cites this paper
• Multifunctional Imidazole-Based Copper(II) Single Crystal for Sustainable Health and Energy Applications

  2026cites this paper
• Impact of copper(II) complexes on increase in lifespan and mean survival of gld-1 mutant strain JK1466 in Caenorhabditis elegans

  2026cites this paper
• A Comparative Study on the Iron and Copper Binding Properties of 8‑Hydroxyquinoline-Derived Mannich Bases Targeting Multidrug-Resistance Cancer Cells

  2026cites this paper
• Mixed ligand Cu(II)-curcumin complexes of diimine co-ligands: Hydrophobicity of 5,6-dmp demonstrates enhanced cytotoxicity with colon cancer cells

  2026cites this paper
• Copper(I) pyrazoline complexes with neutral N, S chelation: Exploring their synthesis, structure, biomolecular interactions, cytotoxic potential, and molecular docking studies

  2026cites this paper
• Design, antibacterial activity, DNA interaction, anticancer and molecular docking analysis of novel bivalent metal chelates based on an no- donor schiff base ligand

  2026cites this paper
• Chitin nanocomposites aided drug delivery: Chitin less explored than chitosan?

  2026cites this paper
• Structure and biomolecular binding behaviour of a polymeric Cu(II) complex with notable anticancer activity

  2026cites this paper
• Synthesis, Structural Studies, and Biological Evaluation of Copper(I) and Copper(II) Complexes Supported by Bis(pyrazol-1-yl)acetate Ligand Functionalized with Amantadine for the Treatment of Glioblastoma

  2026cites this paper
• Chirality-controlled biomolecular recognition in Cu(I) metallodrugs: the first enantiomorphic CuP2O2 systems with dual DNA/LOX activity.

  2026cites this paper
• Biomedical potential of novel copper(II) complexes: From synthesis and characterization to biointeraction profiles and molecular docking approaches

  2026cites this paper
• Unveiling the chemistry of polynuclear copper complexes: current synthetic strategies, properties and emerging applications

  2026cites this paper
• Copper complexes mediate the in situ production of reactive oxygen species in the nucleus, enhancing the anti-tumor efficacy of PTX

  2026cites this paper
• Copper(II) Complexes with Schiff Bases Derived from 2-Pyridinecarbaldehyde N-Oxide and Amino Acids: Studies on DNA, BSA Binding, Nuclease Activity, and Cytotoxicity.

  2025cites this paper
• Targeting the mitochondrial-autophagy axis in pituitary neuroendocrine tumors via intracellular copper overload

  2025cites this paper
• The potential impact of GLS and PDHA1 on tumor immunity and immunotherapy response in LUSC

  2025cites this paper
• Nanoparticles induced cuproptosis to enhance antitumor immunotherapy

  2025cites this paper
• Bilosomal Encapsulation of Binuclear Phosphino Ru(II)–Cu(II) Compounds Enhances Their Selectivity and Activity toward Lung and Prostate Cancers

  2025cites this paper
• Structural variations in copper(II) amine-bisphenolate complexes: Evaluation of in vitro antiproliferative activity against human cancer and normal cells

  2025cites this paper
• Lysosome-targeted theranostics: Integration of real-time fluorescence imaging and controlled drug delivery via Zn(II)-Schiff Base complexes.

  2025cites this paper
• Two crystal structures of copper(II) complexes and adducts based on the neutral N1,N1-dimethyl-N2-(pyridin-2-ylmethyl)ethane-1,2-diamine ligand

  2025cites this paper
• Enhanced photoinduced antimicrobial properties of a copper(II) polypyridine naphthalene diimide complex for wound infection treatment and biomolecular interactions.

  2025cites this paper
• Recent advances in the synthesis, structure, property and application of copper(II) complexes of salicylaldehyde thiosemicarbazone derivatives

  2025cites this paper
• Vicinal Dioxime – Based copper(II) complex: Synthesis, characterization, SOD/catalase, DNA/HAS binding, anticancer and molecular docking studies

  2025cites this paper
• Synthesis, Structure, DNA/BSA Binding, DNA Cleaving, Cytotoxic and SOD Mimetic Activities of Copper(II) Complexes Derived from Methoxybenzylamine Schiff Base Ligands

  2025cites this paper
• Targeting Triple Negative Breast Cancer with a Dinuclear Copper(II) Thiocarbohydrazone Complex: Efficacy Evaluation and Cellular Response

  2025cites this paper
• Pyrazole-Infused Metal Complexes: Anticancer Activity, DNA Cleavage, and Biophysical Insights into DNA/BSA Interactions.

  2025cites this paper
• Copper(I) complexes of a Triazine Derived Schiff Base: Synthesis, Crystal Structure and Biological Applications

  2025cites this paper
• Unlocking on the effect of gold cluster with pregabalin, a bioactive molecule: Solvation, SERS and reactivity analysis

  2025cites this paper
• Stimulation of the immune system and apoptosis induction by new cobalt(III) H2salophen complexes in breast cancer mouse model and docking calculations

  2025cites this paper
• Cobalt(III) complexes with dihalo-substituted 8-hydroxyquinoline ligands: Synthesis, characterization, and anticancer evaluation

  2025cites this paper
• Discovery of Cu(II)-Dipyridophenazine Complex for Synergistic Cuproptosis/Chemodynamic Therapy via Disrupting the Tricarboxylic Acid (TCA) Cycle in Metastatic TNBC.

  2025cites this paper
• Recent advances of HKUST-1 metal–organic frameworks in the biomedical applications: A comprehensive review

  2025cites this paper
• Advancements in Metal Complexation of Pyridine Derivatives (2022-2024): A Pathway to Enhanced Anticancer Potency.

  2025cites this paper
• Rational Design of Heterometallic Water-Soluble Yttrium Complexes with Selective In Vitro and In Vivo Anticancer Activity

  2025cites this paper
• Selected thiazole-based M(II) complexes (M = Cu, Ni, or Co): Harnessing metal–ligand synergy against bacterial and fungal pathogens

  2025cites this paper
• Dinuclear cu(II) and Ni(II) complexes with Bis(Pyridylimine) ligands: Comparative analysis of the reactivity of ligated imine and an in-depth investigation of the DNA/complex interactions

  2025cites this paper
• Recent Advances in Metal-based Drugs in Cancer Therapy

  2025cites this paper
• Structural insights and in vitro and in vivo anticancer evaluation of dithiocarbamate-based metal complexes against murine lymphoma.

  2025cites this paper
• Therapeutic applications of quercetin-metallic complexes: a review

  2025cites this paper
• First-row transition metal complexes of naturally occurring anticancer chelators for cancer treatment

  2025cites this paper
• DDTC-Cu(I) Nano-MOF Induces Ferroptosis by Targeting SLC7A11/GPX4 Signal in Colorectal Cancer.

  2025cites this paper
• Design and Synthesis of Bimetallic Cu(II) Compounds as Potent Antibacterial and Antibiofilm Agents with Metallo- β -Lactamase Inhibitory Activityagainst Multidrug Resistant Pseudomonas aeruginosa.

  2025cites this paper
• Synthesis, Structural Analysis, Computational Investigation, and Cytotoxicity Studies of New Copper(II) Coordination Polymers

  2025cites this paper
• Antibacterial Efficacy of (N, O)-Linked Cu-MOF: Experimental and Theoretical Insights

  2025cites this paper
• Microbiological applications of the saccharinatecopper(II) complex (Cu-Sac).

  2025cites this paper
• Halogen‐Containing Carbene and Carbene–Phenanthroline Complexes of Copper(I). Synthesis, Structure, and Antimicrobial Activity

  2025cites this paper
• Synthesis, characterization, crystal structure, DFT study, antimicrobial and anticancer activities of a novel Cu(II) complex derived from N-(furan-2-ylmethyl)-1 (5-methyl-1H-pyrazol-3-yl)methanimine

  2025cites this paper
• Recent research progress of β-carbolines as privileged scaffold in the discovery of anticancer agent (2019-2024).

  2025cites this paper
• Preclinical Trials of Cancer Stem Cells Targeted by Metal-Based Coordination Complexes: A Systematic Review

  2025cites this paper
• Development and evaluation of a Cu(II) complex as nanosuspension for enhanced antitumor efficacy against glioblastoma cancer

  2025cites this paper
• Copper pyrithione, a copper complex ATG4B and autophagy inhibitor, exhibits potent anticancer effects

  2025cites this paper
• Novel zinc(II) complexes bearing N,N,N-tridentate pyrimidine ligands as antitumor agents: Synthesis, characterization and antitumor evaluation.

  2025cites this paper
• Unravelling the structural insights and in vitro biomolecular interactions of new bioactive copper(II) based chemotherapeutic agents by spectroscopic and computational methods

  2025cites this paper
• Copper dependent in situ aggregation of engineered Au Pt nanoalloy for on-demand photothermal-photodynamic-chemodynamic therapy with real-time guidance of AIE imaging to accurately treat malignant tumor

  2025cites this paper
• Design, synthesis, and cytotoxic potential of a series of palladium complexes with varying chain lengths against human breast carcinoma cells

  2025cites this paper
• Redox-Engineered Copper(II) Methylthio-Imidazole Schiff Base Complex for Electrochemical Detection of Creatinine as a Kidney Disease Biomarker

  2025cites this paper
• Structural, anticancer and antioxidant studies of 1-oxomelamine and its copper(II) complex

  2025cites this paper
• A new approach in coordination chemistry from the perspective of the mechanism of antitumor activity of selected heterometallic complexes

  2025cites this paper
• Synthesis, Characterization, and Biomolecular Interactions of a novel Copper(II) Complex: DNA and BSA Binding Studies

  2025cites this paper
• Dendritic metallodrugs: An overview of their anticancer properties

  2025cites this paper
• Piperazine-Based Co(III), Ni(II), Cu(II), and Zn(II) Carbodithioate Complexes as Potential Anticancer Agent

  2025cites this paper
• Apoptotic cell death induced by copper (II), manganese (II) and silver (I) complexes containing bridging dicarboxylate and 1,10-phenanthroline ligands: one of the multi-modes of anticancer activity?

  2025cites this paper
• Synthesis, Structure, and Stability of Copper(II) Complexes Containing Imidazoline-Phthalazine Ligands with Potential Anticancer Activity

  2025cites this paper
• Copper(II) Cyclopeptides with High ROS-Mediated Cytotoxicity

  2025cites this paper
• Two new square-planar Cu(II) complexes derived from a heterocyclic pyrazolone ligand: synthesis, in vitro anticancer activity, DFT and Hirshfeld analysis

  2025cites this paper
• Binding of potential antitumor Casiopeínas® to small proteins.

  2025cites this paper
• Exploring the therapeutic potential of copper and cobalt complexes as anticancer agents: a comprehensive review

  2025cites this paper
• Spectroscopic Analysis of Copper Minocycline Novel Complex and Evaluation of its Potent Antibacterial, Antioxidant and Anti-breast Cancer (MCF-7) Properties

  2025cites this paper
• Hydrazonate-Based Copper(II) Metallodrugs: Insights into Solution Behavior, G-Quadruplex DNA Interaction, and Anticancer Potential.

  2025cites this paper
• Copper-based nanoplatforms and their role in cancer therapy

  2025cites this paper
• Copper (II) complexes of azo phenolate ligands: Synthesis, crystal structure, functional mimetic, and anticancer study

  2025cites this paper
• Studies on the Effect of Diamine Elongation in Copper(II) Complexes with NNO Tridentate Schiff Base Ligands

  2025cites this paper
• Multifunctional Bioactivity of the [Cu(en)(Im)2](ClO4)2 Complex: Antimicrobial, Antibiofilm, and Anticancer Effects

  2025cites this paper
• Synthesis, Characterization, and Preliminary In Vitro Anticancer Activity of Zinc Complexes Containing Amino Acid-Derived Imidazolium-Based Dicarboxylate Ligands

  2025cites this paper
• Ruthenium(II) and copper(II) polyamine complexes as promising antitumor agents: synthesis, characterization, and biological evaluation.

  2025cites this paper
• Development of novel coordination polymeric metal complexes with potent antimicrobial and antitumor activity

  2025cites this paper
• Research progress on cuproptosis and copper related anti-tumor therapy

  2025cites this paper
• Mechanical and Covalent Tailoring of Copper Catenanes for Selective Aqueous Nitrate-to-Ammonia Electrocatalysis

  2025cites this paper
• New Cu(II), Cu(I) and Ag(I) Complexes of Phenoxy-Ketimine Schiff Base Ligands: Synthesis, Structures and Antibacterial Activity

  2025cites this paper
• Support for the Anticipated Binding Mode of a Cytotoxic Dinuclear Copper Complex to Two Neighboring Phosphate Esters of the DNA Backbone.

  2025cites this paper
• Harnessing redox reactions for anticancer effects: A copper(II) Schiff base complex induces apoptosis in HepG2 liver cancer cells via ROS generation.

  2025cites this paper
• Some Biological Applications and Mechanistic Insights of Benzaldehyde‐Substituted Thiosemicarbazones and Their Metal Complexes: A Review

  2025cites this paper
• Interaction studies of biliverdin-Cu complex formation using XANES, XRF, and DFT analyses and its effect on cytotoxicity in glioblastoma cell line (U251).

  2025cites this paper
• Impact of Chelation on Reactivity and Cytotoxicity of Hemilabile Biphenyl Gold(III) N‐Heterocyclic Carbene Complexes

  2025cites this paper
• Synthesis and Preliminary Cytotoxicity Evaluation of 3-Lup-20(29)-Ene-3β,28-Diol Glycoconjugates Containing a Succinic Linker and a 1,2,3-Triazole Ring

  2025cites this paper
• The Effect of Anion, Steric Factors on the Catalytic Activity of Hydrogen Peroxide, Biological Activities, Docking, and DFT Calculations of Novel Mixed Ligand of Copper Complexes

  2025cites this paper
• A green marriage: the union of theophylline's catalytic activity and healing potential

  2025cites this paper
• Modelling the binding of cytotoxic dinuclear nickel complexes to two neighboring phosphate esters of DNA using dicarboxylate ligands.

  2025cites this paper
• Synthesis of new Ag(i) and Cd(ii) hydrozanomide-based complexes with antibacterial and anticancer properties

  2025cites this paper
• Hybrid thiazolyl–benzylidene–phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, in vitro and in silico studies

  2025cites this paper
• Investigation of the Cytotoxicity of Cu(II), Au(III), and Pd(II) Complexes with 2,4-Dithiouracil and 6-Propyl-2-thiouracil Derivatives

  2025cites this paper
• Synthesis, crystal structure, spectral properties, and charge density analysis of 4-coordinate Bis[1-(4-N,N-dimethylaminophenyl)-1,3-butadionato-O,O′]copper(II)

  2025cites this paper
• Molecular docking insights and bioactivity of Schiff base–copper(II) complexes: exploring enzymatic and non-enzymatic antioxidant properties and α- chymotrypsin inhibition

  2025cites this paper
• Hydroxypyranone–metal complexes in anticancer therapy: from structural design to mechanistic insights

  2025cites this paper
• A Multifaceted Nanodrug Disrupts the Copper-Iron Homeostasis to Enhance Cancer Radiotherapeutic Effect.

  2025cites this paper
• Recent Advances in Schiff Base Coinage Metal Complexes as Anticancer Agents: A Comprehensive Review (2021–2025)

  2025cites this paper